US · Healthcare

Zentalis Pharmaceuticals Llc (ZNTL)

Biotechnology

Zentalis Pharmaceuticals Llc (ZNTL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZNTL

P/E ratio

18.00

Zentalis Pharmaceuticals Llc (ZNTL) — FAQ

What is ZNTL's P/E ratio?

The price-to-earnings (P/E) ratio for Zentalis Pharmaceuticals Llc (ZNTL) is 18.00 (data as of 2026-03-24).

Does Zentalis Pharmaceuticals Llc pay a dividend?

Dividend yield is not available in the current snapshot for Zentalis Pharmaceuticals Llc (ZNTL). Check the MyAverix Finance app for the latest dividend data.

What sector is Zentalis Pharmaceuticals Llc in?

Zentalis Pharmaceuticals Llc (ZNTL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ZNTL listed on?

ZNTL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)